Article
Association of platelet ITGA2B and ITGB3 polymorphisms with ex vivo antiplatelet effect of ticagrelor in healthy Chinese male subjects.
International journal of hematology - 1 Mar 2014
Li Mu-Peng, Xiong Yan, Xu An, Zhou Ji-Peng, Tang Jie, Zhang Zan-Ling, Zhou Hong-Hao, Zhang Wei, Chen Xiao-Ping
Abstract excerpt
Ticagrelor (TIC) is the first reversible P2Y12 receptor antagonist that exhibits rapid antiplatelet effect by indirect inhibition of the GPIIb/IIIa complex. Polymorphisms in genes coding GPIIb/IIIa, namely ITGA2B and ITGB3, are associated with aspirin resistance and risk for thrombotic diseases. We assessed whether ITGA2B and ITGB3 polymorphisms can influence the ex vivo antiplatelet activity of ticagrelor in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
